Xospata (gilteritinib) - Astellas
Vanflyta (quizartinib) - Daiichi Sankyo
Nexavar (sorafenib) - Bayer, Amgen
Rydapt (midostaurin) - Novartis
crenolanib besylate (ARO-002) - AROG
https://ash.confex.com/ash/2020/webprogram/Paper140386.html
 
Betul Oran, MD, MS1; Stefan O. Ciurea, MD2; Partow Kebriaei, MD3; Rohtesh S. Mehta, MD, MPH, MS4; Uday R. Popat, MD4; Chitra Hosing, MD3; Jessica M McCarty, RN3; Bridget Hindman, PhD5; Boo Messahel, MD5; Richard E. Champlin, MD3
 
Nov 5, 2020
 
Prev Next